Discovery of New Medication for the Treatment of Depression Comorbid with Inflammatory Diseases

Curr Top Med Chem. 2018;18(16):1393-1394. doi: 10.2174/156802661816181107142751.

Authors

Hande Sipahi¹, Beril Kadıoğlu², F Esra Önen Bayram³

Affiliations

¹ Department of Toxicology Faculty of Pharmacy Yeditepe University Istanbul, Turkey.
² Department of Pharmacology Faculty of Pharmacy Yeditepe University Istanbul, Turkey.
³ Department of Pharmaceutical Chemistry Faculty of Pharmacy Yeditepe University Istanbul, Turkey.

PMID: 30497355
DOI: 10.2174/156802661816181107142751

No abstract available

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Publication types

Editorial

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Antidepressive Agents / therapeutic use*
Comorbidity
Depression / drug therapy*
Depression / epidemiology
Depressive Disorder / drug therapy*
Depressive Disorder / epidemiology
Drug Discovery*
Humans

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antidepressive Agents